These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14506477)

  • 21. Insertion of the bacterial type III translocon: not your average needle stick.
    Coombes BK; Finlay BB
    Trends Microbiol; 2005 Mar; 13(3):92-5. PubMed ID: 15737725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outer membrane vesicles function as offensive weapons in host-parasite interactions.
    Amano A; Takeuchi H; Furuta N
    Microbes Infect; 2010 Oct; 12(11):791-8. PubMed ID: 20685339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands.
    Mecsas JJ; Strauss EJ
    Emerg Infect Dis; 1996; 2(4):270-88. PubMed ID: 8969244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VirB8: a conserved type IV secretion system assembly factor and drug target.
    Baron C
    Biochem Cell Biol; 2006 Dec; 84(6):890-9. PubMed ID: 17215876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacterial secretion systems: their function and contribution to disease process].
    Abe A
    Kansenshogaku Zasshi; 2009 Mar; 83(2):94-100. PubMed ID: 19364035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state.
    Raab R; Swietnicki W
    Protein Expr Purif; 2008 Mar; 58(1):53-60. PubMed ID: 18160307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How bacterial pathogens use type III and type IV secretion systems to facilitate their transmission.
    Byndloss MX; Rivera-Chávez F; Tsolis RM; Bäumler AJ
    Curr Opin Microbiol; 2017 Feb; 35():1-7. PubMed ID: 27621139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of type III secretion systems.
    Francis MS; Wolf-Watz H; Forsberg A
    Curr Opin Microbiol; 2002 Apr; 5(2):166-72. PubMed ID: 11934613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics as a probe of microbial pathogenesis and its molecular boundaries.
    Bhavsar AP; Auweter SD; Finlay BB
    Future Microbiol; 2010 Feb; 5(2):253-65. PubMed ID: 20143948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Dsb proteins of Gram-negative bacteria in the process of pathogenesis.
    Łasica AM; Jagusztyn-Krynicka EK
    FEMS Microbiol Rev; 2007 Sep; 31(5):626-36. PubMed ID: 17696887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Conserved and Species-Specific Functions of the Listeria monocytogenes PrsA2 Secretion Chaperone.
    Cahoon LA; Freitag NE
    Infect Immun; 2015 Oct; 83(10):4028-41. PubMed ID: 26216425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishing order for type III secretion substrates--a hierarchical process.
    Thomas NA; Brett Finlay B
    Trends Microbiol; 2003 Aug; 11(8):398-403. PubMed ID: 12915098
    [No Abstract]   [Full Text] [Related]  

  • 34. Assembly and structure of the T3SS.
    Burkinshaw BJ; Strynadka NC
    Biochim Biophys Acta; 2014 Aug; 1843(8):1649-63. PubMed ID: 24512838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukotoxins.
    Srikumaran S
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32272577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospects for the development and use of gram-negative bacterial virulence protein secretion inhibitors for prophylaxis and treatment of infectious diseases.
    Felise HB; Miller SI
    Crit Rev Immunol; 2010; 30(1):69-77. PubMed ID: 20370621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular proteases and possible disease related virulence mechanisms of two marine bacteria implicated in an opportunistic bacterial infection of Nephrops norvegicus.
    Ridgway ID; Small HJ; Atkinson RJ; Birkbeck HT; Taylor AC; Neil DM
    J Invertebr Pathol; 2008 Sep; 99(1):14-9. PubMed ID: 18617185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The multitalented type III chaperones: all you can do with 15 kDa.
    Feldman MF; Cornelis GR
    FEMS Microbiol Lett; 2003 Feb; 219(2):151-8. PubMed ID: 12620614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of the Yersinia enterocolitica type III secretion translocator chaperone SycD.
    Büttner CR; Sorg I; Cornelis GR; Heinz DW; Niemann HH
    J Mol Biol; 2008 Jan; 375(4):997-1012. PubMed ID: 18054956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conserved features of type III secretion.
    Tampakaki AP; Fadouloglou VE; Gazi AD; Panopoulos NJ; Kokkinidis M
    Cell Microbiol; 2004 Sep; 6(9):805-16. PubMed ID: 15272862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.